In a murine model of CD8 T cell-driven renal autoimmunity (NOH mice with podocyte-restricted ovalbumin expression and pathogen-primed autoreactive OT-1 cytotoxic T cells), autoreactive tissue-resident memory T cells (TRMT_{RM}) emerge and persist in the kidney while their circulating memory counterparts disappear, orchestrating immune-mediated nephritis. What remains unresolved is the lineage origin of these kidney-resident autoreactive CD8 TRMT_{RM}: whether they differentiate locally within the inflamed kidney from infiltrating cytotoxic T lymphocytes, or are seeded by a distinct circulating precursor population poised for tissue residency (single-cell data identify a candidate day-7 circulating cluster with a TRMT_{RM}-precursor-like transcriptome, but no lineage tracing was performed). The coupled maintenance question — how these resident populations are sustained, self-renewed, or replenished from the periphery during chronic disease — is likewise open. Resolving this lineage problem would determine at which stage intervention should act to prevent self-reactivity from becoming chronic organ disease.

Background

Tissue-resident memory T cells (TRMT_{RM}) are memory T cells that take up long-term residence in peripheral tissues rather than recirculating through blood; they are commonly marked by the retention receptors CD69 and CD103 and provide rapid local protection against pathogens, but can also drive chronic inflammatory and autoimmune disease. Which route generates TRMT_{RM} in a given organ — local maturation of effector cytotoxic T lymphocytes (CTLs, the killer CD8 T cell effector stage) that have infiltrated the tissue, versus recruitment of a distinct circulating precursor already transcriptionally primed for residency — is a central, tissue-dependent question of TRMT_{RM} biology, and the two routes can leave identical steady-state phenotypes, so distinguishing them requires lineage-tracing designs such as fate mapping (genetically marking a defined cell population so that its descendants remain identifiable later), parabiosis (surgically joining the circulations of two animals so that circulating cells equilibrate while tissue-resident cells do not), or adoptive transfer of sorted candidate precursors.

The kidney is a clinically important but poorly traced case. Immune-mediated nephritis — inflammation of kidney tissue driven by responses against self-antigens or innocuous substances — is a leading cause of acute kidney injury and chronic kidney disease, and kidney biopsies regularly contain T cell infiltrates whose density correlates with loss of renal function. The advent of immune-checkpoint inhibitors (ICI, antibodies releasing brakes such as PD-1 on T cells, used in oncology) has produced new forms of T cell-mediated kidney inflammation, including acute interstitial nephritis (AIN, inflammation of the kidney tubulointerstitium), renewing interest in cellular immunity to renal autoantigens.

Arnold et al. (2024) established a murine model to follow autoreactive CD8 T cell fate in the kidney: NOH mice, which carry nephrin-promoter-driven transgenes encoding membrane-bound chicken ovalbumin (OVA) and hen egg lysozyme (HEL) as model renal autoantigens, with OVA displayed on podocytes (visceral glomerular epithelial cells), received OVA-specific OT-1 CTLs carrying a transgenic T cell receptor (TCR, the antigen receptor of T cells, here engineered to recognize an OVA-derived peptide) that were activated by subclinical OVA-expressing Listeria infection. To sustain cellular immunity into a chronic phase, mice then received a booster infection with OVA-expressing vesicular stomatitis virus (VSV-OVA) on day 21 or, in a separate cohort, weekly OVA injections instead of the booster, with endpoint analyses at early (day 7) and late (days 35–56) time points. Renal autoantigen is transported through proximal tubular epithelial cells (PTECs) to periglomerular antigen-presenting cells, which cross-present it (re-display internalized antigen on MHC class I to CD8 T cells) to sustain a local CTL response. Circulating OT-1 memory cells rapidly disappeared, while CD69- and CD103-expressing OT-1 TRMT_{RM} accumulated and persisted in periglomerular and peritubular infiltrates, driving progressive nephritis. In the weekly-OVA cohort, no transferred cells were detected in peripheral blood after 5 weeks while renal CD69+/CD103+ OT-1 fractions remained high (66.8 vs. 8.0% in wild-type hosts), leading the authors to propose that autonomous renal TRMT_{RM} populations might drive local self-reactivity without continuous replenishment from the periphery — an inference from endpoint observations rather than lineage tracing. Comparable CD69+/CD103+ T cell populations were found in kidneys of patients with autoimmune nephritis, including AIN and ICI-related nephritis. Single-cell RNA sequencing of day-7 circulating OT-1 cells revealed one cluster (cluster 7) expressing a TRMT_{RM}-precursor-like program (upregulated Itgae/CD103, Cd69, Xcl1, Ahr, Nr4a1, Egr2, P2rx7; downregulated Klf2 and S1pr1, factors that promote tissue exit and circulation), but the authors did not trace its fate, and they explicitly state that it remains uncertain whether the renal TRMT_{RM} differentiate locally from infiltrating CTLs or derive from distinct circulating precursors, promoting further studies on the origin and replenishment of kidney-specific TRMT_{RM}. Adjacent work in kidney transplantation sharpens the stakes: in allografts (transplanted organs attacked by recipient T cells), recipient effector T cells have been shown to differentiate into functional TRMT_{RM} under persistent antigen exposure (Abou-Daya et al. 2021), and single-cell and spatial transcriptomics of rejecting kidney grafts suggest effector CD49a+PD1hi CD8 TRMT_{RM} may mature from a CXCR6hi precursor-like state in graft tertiary lymphoid structures (organized lymphocyte aggregates that form within chronically inflamed tissue) in a BHLHE40 transcription-factor-dependent manner (Li et al. 2026) — but these are alloimmune settings, rest on transcriptomic inference rather than lineage tracing, and leave the autoantigen-driven renal question open.

Problem Statement

In a renal autoimmunity model in which autoreactive CD8 cytotoxic T cells recognize a podocyte-restricted renal autoantigen (as in the NOH-OVA/OT-1 system of Arnold et al. 2024), determine the cellular origin and differentiation pathway of the kidney-resident autoreactive CD8 TRMT_{RM} population: do these cells differentiate locally within the kidney from infiltrating effector CTLs, or are they seeded during early inflammation by a distinct circulating precursor population poised for tissue residency (such as the day-7 cluster-7-like cells with upregulated Itgae, Cd69, Xcl1, Ahr, Nr4a1, Egr2, P2rx7 and downregulated Klf2/S1pr1)? The answer must establish which route (local differentiation, seeding by a circulating precursor, or a mixture of both; a qualitative determination of the predominant route is sufficient on its own, and a quantitative mix of routes and any disease-phase dependence should be reported where the experimental design can resolve them) holds, and — jointly, as the coupled maintenance face of the same lineage question — determine how the established renal TRMT_{RM} population is then sustained during the chronic phase of disease (the persistent renal inflammation produced in the source model by booster antigen exposure after priming, either a day-21 VSV-OVA booster infection or weekly OVA injections, and extending to the late time points such as days 35–56 at which renal TRMT_{RM} persist while circulating memory cells have disappeared): in situ self-renewal versus continued replenishment from the periphery. Effector mechanisms of injury, validation across human AIN etiologies, and preclinical testing of PD-L1-based therapy are out of scope.

References

  1. Arnold F, Kupferschmid L, Weissenborn P, Heldmann L, Hummel JF, Zareba P, Sagar, Rogg M, Schell C, Tanriver Y (2024). Tissue-resident memory T cells break tolerance to renal autoantigens and orchestrate immune-mediated nephritis. Cellular & Molecular Immunology 21(9):1066–1081. DOI: 10.1038/s41423-024-01197-z. https://www.nature.com/articles/s41423-024-01197-z
  2. Abou-Daya KI, Tieu R, Zhao D, Rammal R, Sacirbegovic F, Williams AL, Shlomchik WD, Oberbarnscheidt MH, Lakkis FG (2021). Resident memory T cells form during persistent antigen exposure leading to allograft rejection. Science Immunology 6(57):eabc8122. DOI: 10.1126/sciimmunol.abc8122. https://doi.org/10.1126/sciimmunol.abc8122
  3. Li J, Yang B, Pan T, Zhou X, Ma Z, Tang D, Xie B, Liu J, Chen Z, Lan P (2026). BHLHE40 Orchestrates Effector Tissue-Resident Memory CD8+ T Cells and Limits Long-Term Survival of Kidney Graft. Advanced Science 13(10). DOI: 10.1002/advs.202520518. https://doi.org/10.1002/advs.202520518
  4. Xu L, Ye L, Huang Q (2025). Tissue-Resident Memory CD8+ T Cells: Differentiation, Phenotypic Heterogeneity, Biological Function, Disease, and Therapy. MedComm 6(3):e70132. DOI: 10.1002/mco2.70132. https://doi.org/10.1002/mco2.70132
  5. Ginsberg P, Panzer U, Asada N (2023). Tissue-resident memory T cells in renal autoimmune diseases. Frontiers in Immunology 14:1111521. DOI: 10.3389/fimmu.2023.1111521. https://doi.org/10.3389/fimmu.2023.1111521
  6. Li X, Ding R, Cai J (2026). Tissue-resident memory T cells in organ transplantation: implications for immune homeostasis and graft outcomes. Inflammation and Regeneration 46(1):24. DOI: 10.1186/s41232-026-00422-8. https://doi.org/10.1186/s41232-026-00422-8
  7. Jiang J, Zhou Y, Yao Y, Weng L, Wang H (2026). Immune checkpoint inhibitor-associated acute interstitial nephritis: Pathogenesis and heterogeneity. CytoJournal 23:50. DOI: 10.25259/cytojournal_68_2026. https://doi.org/10.25259/cytojournal_68_2026